Serum sickness-like reactions most commonly occur secondary to drug administration. We describe a serum sickness-like reaction that was possibly associated with meropenem therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/374932 | DOI Listing |
JAAD Case Rep
February 2025
Piedmont Plastic Surgery and Dermatology, Charlotte, North Carolina.
J Allergy Clin Immunol Pract
January 2025
Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati OH; Department of Pediatrics, University of Cincinnati College of Medicine. Electronic address:
JAAD Case Rep
January 2025
Department of Dermatology, Medical College of Georgia at Augusta University, Augusta, Georgia.
Children (Basel)
November 2024
Division of Gastroenterology, Department of Pediatrics, University of New Mexico, Albuquerque, NM 87131, USA.
Infliximab (IFX) is a recombinant DNA-derived chimeric IgG monoclonal antibody protein that inhibits tumor necrosis factor alpha (TNF-α). IFX, like other agents derived from foreign proteins, can cause infusion reactions both during and after the infusion. The incidence of infusion reactions ranges between 0% and 15% in pediatric patients.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
December 2024
Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Mo; University of Missouri-Kansas City School of Medicine, Kansas City, Mo. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!